Physician profile
Jane Yoo
NPI 1447571518
$41,763.44
in general payments reported to CMS, 2019-2025
19 companies · $19K in 2025
The $19K reported for 2025 was more than what 97% of Mohs-Micrographic Surgery providers received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $806 · 2020: $368 · 2021: $3,537 · 2022: $2,379 · 2023: $11K · 2024: $4,536 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Food and Beverage: $11K · Travel and Lodging: $4,431 · Gift: $43.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $19,075.00 |
| Food and Beverage | $11,124.53 |
| Travel and Lodging | $4,430.55 |
| Gift | $43.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $11,651.02 | 2023-2025 | |
| Incyte Corporation | $11,515.74 | 2023-2025 | Opzelura |
| Lumenis Be INC | $7,990.68 | 2023-2024 | M22 |
| Genzyme Corporation | $3,201.13 | 2020-2021 | |
| Arcutis Biotherapeutics, INC. | $2,281.33 | 2023-2024 | Zoryve |
| Biofrontera INC. | $1,565.13 | 2021-2023 | Ameluz, Xepi, Bf-Rhodoled |
| Galderma Laboratories, L.P. | $1,430.98 | 2019-2025 | Aklief |
| Sun Pharmaceutical Industries INC. | $764.37 | 2019-2023 | Absorica Ld, Winlevi, Ilumya |
| Merz North America, INC. | $422.74 | 2022-2024 | |
| Genentech USA, INC. | $242.92 | 2019-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $192.92 | 2019-2022 | |
| Pfizer INC. | $135.98 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $103.15 | 2019 | |
| Dermira, INC. | $83.28 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $49.82 | 2024 | Sotyktu |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $45.61 | 2020 | |
| Regeneron Pharmaceuticals, INC. | $45.00 | 2019 | |
| Amgen INC. | $22.82 | 2021 | |
| Medimetriks Pharmaceuticals, INC. | $18.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Yoo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.